These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37477838)

  • 1. Balancing Intelectual Property Protection and Legal Risk Assessment in Registration of Covid-19 Vaccines in Malaysia.
    Ahamat H; Sa'ban H; Manap NA
    Health Care Anal; 2023 Dec; 31(3-4):196-207. PubMed ID: 37477838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
    Bai AY; Zhang B; Jiang Y; Qiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic.
    Altindis E
    Expert Rev Vaccines; 2022 Apr; 21(4):427-430. PubMed ID: 34878957
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 Vaccination: Guidance for Ethical, Informed Consent in a National Context.
    Little DT; Šeman EI; Walsh AL
    Issues Law Med; 2021; 36(2):127-162. PubMed ID: 36629774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity.
    Park SP; Lee HJ; Yu Y; Lee EYJ; Park YS
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
    Louden EM
    Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to COVID-19 Vaccines: A New Global Approach.
    Bouderhem R
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canada and the pharmaceutical industry in the time of COVID-19.
    Lexchin J
    Int J Soc Determinants Health Health Serv; 2023 Oct; 53(4):508-517. PubMed ID: 37574784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Access to anti-covid vaccines: research, development and role of patents.].
    Formoso G; Mancini S
    Recenti Prog Med; 2021; 112(7):499-503. PubMed ID: 34263876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
    Ng JWJ; Vaithilingam S; Nair M; Hwang LA; Musa KI
    PLoS One; 2022; 17(5):e0268926. PubMed ID: 35604921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences, coping strategies and perspectives of people in Malaysia during the COVID-19 pandemic.
    Cheah PK; Jalloh MB; Cheah PK; Ongkili D; Schneiders ML; Osterrieder A; Peerawaranun P; Waithira N; Davies A; Mukaka M; Cheah PY
    BMC Public Health; 2023 Jun; 23(1):1085. PubMed ID: 37280573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halal or Haram? The COVID-19 Vaccine Discussion Among Twitter users in Malaysia.
    Mohd Jenol NA; Ahmad Pazil NH
    J Relig Health; 2023 Aug; 62(4):2933-2946. PubMed ID: 36964281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Coronavirus Disease 2019 Vaccines: Need for Informed Consent.
    Mazraani M; Barbari A
    Exp Clin Transplant; 2021 Aug; 19(8):753-762. PubMed ID: 34407747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.